List of Antigen Express patents | 8 results

Name	Description	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 9289487 II-key/antigenic epitope hybrid peptide vaccines	Patent 9289487 was granted and assigned to Antigen Express on March, 2016 by the United States Patent and Trademark Office.	‌ Antigen Express	United States Patent and Trademark Office	9289487	March 22, 2016
‌ US Patent 7179645 Ii-Key/antigenic epitope hybrid peptide vaccines	Patent 7179645 was granted and assigned to Antigen Express on February, 2007 by the United States Patent and Trademark Office.	‌ Antigen Express	United States Patent and Trademark Office	7179645	February 20, 2007
‌ US Patent 7205274 Hybrid peptides modulate the immune response	Patent 7205274 was granted and assigned to Antigen Express on April, 2007 by the United States Patent and Trademark Office.	‌ Antigen Express	United States Patent and Trademark Office	7205274	April 17, 2007
‌ US Patent 7935350 Ii-key/Her-2/neu hybrid cancer vaccine	Patent 7935350 was granted and assigned to Antigen Express on May, 2011 by the United States Patent and Trademark Office.	‌ Antigen Express	United States Patent and Trademark Office	7935350	May 3, 2011
‌ US Patent 8815249 Ii-key/antigenic epitope hybrid peptide vaccines	Patent 8815249 was granted and assigned to Antigen Express on August, 2014 by the United States Patent and Trademark Office.	‌ Antigen Express	United States Patent and Trademark Office	8815249	August 26, 2014
‌ US Patent 7541334 Hybrid peptides modulate the immune response	Patent 7541334 was granted and assigned to Antigen Express on June, 2009 by the United States Patent and Trademark Office.	‌ Antigen Express	United States Patent and Trademark Office	7541334	June 2, 2009
‌ US Patent 8889143 Ii-key/HER-2/neu hybrid cancer vaccine	Patent 8889143 was granted and assigned to Antigen Express on November, 2014 by the United States Patent and Trademark Office.	‌ Antigen Express	United States Patent and Trademark Office	8889143	November 18, 2014
‌ US Patent 8748130 Human papillomavirus / Ii-Key hybrids and methods of use	Patent 8748130 was granted and assigned to Antigen Express on June, 2014 by the United States Patent and Trademark Office.	‌ Antigen Express	United States Patent and Trademark Office	8748130	June 10, 2014